MD Conference Express ICAAC 2011 - (Page 2)

Dear Colleagues, On behalf of the American Society of Microbiology (ASM), I am pleased to present the official peer-reviewed highlights of ICAAC 2011, held in September in Chicago, Illinois. We chose to partner with MD Conference Express® on this special issue because of their unique, peer-reviewed approach to conference highlights reporting. There is a very real need for a scientifically vetted overview of key findings from major conferences like ICAAC. While in most cases, the science presented at a major conference like ICAAC has not undergone the rigors of peer-review for publication in a scientific journal, the data presented through the trials, posters, and special sessions may provide useful information for practitioners. The careful process used in creating these conference highlights provides reassurance that the content of the presentations is being accurately represented. In addition to coverage of top clinical trials, other topics selected for this special edition include antibiotic resistance, drug discovery and vaccines. These topics were determined in direct consultation with the scientific leadership of the ASM. All articles were written strictly from primary source data (no press releases, no third-party opinion). The faculty who presented these data live were invited to review and comment on the resulting articles. Finally, an independent board of world experts reviewed the content to ensure accuracy and a balanced perspective. This is a new approach to conference highlights reports – and one which the ASM felt would of service to its members. I hope you enjoy this special edition of MD Conference Express and find it to be useful to your practice. We welcome your comments on this new initiative and please plan to join us in San Francisco for the ICAAC 2012. You can learn more at www.icaac.org. M. Lindsay Grayson, MD Chair, ICAAC Program Committee Austin Hospital,Melbourne, Australia Craig E. Rubens, MD, PhD Vice-Chair, ICAAC Program Committee Seattle Children’s Hospital Research Institute Seattle, Washington, USA 2 November 2011 www.mdconferencexpress.com  http://www.mdconferencexpress.com http://www.icaac.org http://www.mdconferencexpress.com

Table of Contents for the Digital Edition of MD Conference Express ICAAC 2011

MD Conference Express ICAAC 2011
Contents
Infectious Disease Genomics
Emerging Resistance Among Gram-Negative Pathogens
Procalcitonin-Guided Antibiotic Therapy In Patients with Lower Respiratory Tract Infections
Combination Therapy with Flucytosine Improves Survival in AIDS-Related Cryptococcal Meningitis
CXA-201 Effective Against Common ICU Pathogens
Tigecycline Plus Standard Therapy Is More Effective For Treating Infections in Febrile Neutropenic Cancer Patients
Interventions Aimed at Reducing MRSA BSIs Led to Decreased Rates of Nosocomial MSSA BSIs
Is the Effectiveness of aP Vaccine in Pre-Adolescents Insufficient?
TMC435 Effective in the Treatment of HCV Genotype 1 Infection
HIV
Vaccines
Antibiotic Resistance
Drug Discovery
The Conundrum of MDR TB and Combination Therapy
New Drugs to Treat MDR Pathogens
Immunizations in Reproductive Health
Why Can’t Microbes Just Get Along?
The Role of Adjunctive Steroids in the Treatment of Bacterial Meningitis
Human and Animal Viruses Share “One World” and Emerging Zoonotic Infections Continue to Threaten

MD Conference Express ICAAC 2011

https://www.nxtbookmedia.com